Health Secretary Robert F. Kennedy Jr. is pushing for a federal review of antidepressants and other psychiatric medications as part of the “Make America Healthy Again” effort.
The New York Times reports that the initiative takes aim at selective serotonin reuptake inhibitors, such as Zoloft, Lexapro, Paxil, and Prozac.
“Psychiatric medications have a role in care, but we will no longer treat them as the default, we will treat them as one option, to be used when appropriate, with full transparency and with a clear path off when they are no longer needed,” Kennedy said at a Mental Health and Overmedicalization Summit. He added, “Let me be clear: If you are taking psychiatric medication, we are not telling you to stop. We are making sure you — and your clinician — have the information and support to make the right decision for you.”
“Our goal is straightforward: to reduce unnecessary dependence on medication, to improve patient outcomes and to return control to the patients,” he said.
Kennedy also sent a “Dear Colleague” letter to providers, urging them to consider “evidence-based non-pharmacological interventions,” which may include “psychotherapy, social connection, behavioral approaches, sleep-focused treatments, physical activity interventions, and dietary and nutrition-related strategies.”
“HHS also encourages regular and deliberate review of psychiatric medication regimens to ensure that each medication remains necessary, beneficial, and aligned with the individual’s current clinical needs and treatment goals. In some circumstances, continued pharmacotherapy remains clearly indicated,” the letter adds. “In others, clinicians and patients may determine that a medication is no longer providing meaningful benefit, is contributing to adverse effects, has become part of an unnecessarily complex regimen, or should be reduced or discontinued following a thoughtful risk-benefit review.”
